Motoki A et al. |
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. |
2008 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:18835921
|
Gross GJ et al. |
Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts. |
2010 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:20400686
|
Merkel MJ et al. |
Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling. |
2010 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:20008276
|
Ye D et al. |
Activation of rat mesenteric arterial KATP channels by 11,12-epoxyeicosatrienoic acid. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15331373
|
Campbell WB et al. |
14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels. |
2002 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:11959628
|
Snyder GD et al. |
Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle. |
2002 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:12384472
|
Falck JR et al. |
Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation. |
2003 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:12388250
|
Medhora M et al. |
Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. |
2003 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:12388259
|
Fang X et al. |
Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide. |
2002 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:12388281
|
Fang X et al. |
Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. |
2004 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15284062
|